World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
115
Citations
84132
World Ranking
4424
National Ranking
88

Overview

Lars Rydén is affiliated with the Karolinska Institute in Sweden, with a research focus primarily in the fields of Medicine, Endocrinology, Diabetes and Metabolism, and Cardiology and Cardiovascular Medicine. Their body of work also spans Epidemiology, Physiology, and Molecular Biology. The main topics addressed in their research include diabetes treatment and management, atrial fibrillation management and outcomes, diet and metabolism studies, metabolism related to diabetes and cancer, antiplatelet therapy and cardiovascular diseases, cardiovascular function and risk factors, as well as diabetes management and research.

Rydén's recent publications demonstrate a focus on diabetes, cardiovascular health, and cognitive outcomes. Noteworthy papers include:

  • Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial (2020, The Lancet Neurology)
  • Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial (2022, European Journal of Heart Failure)
  • The history of the Nobel prize for the discovery of insulin (2021, Diabetes Research and Clinical Practice)
  • Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline (2020, Stroke)
  • Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial (2022, European Heart Journal - Cardiovascular Pharmacotherapy)

Frequent collaborators include Giulia Ferrannini, Linda Mellbin, Anna Norhammar, Jeffrey L. Probstfield, and Gilles R. Dagenais, each contributing to multiple joint publications with Rydén.

The scientist's work has been published regularly in several venues with Cardiovascular Diabetology and European Heart Journal each hosting four of their papers, Diabetes Research and Clinical Practice presenting three, and single publications appearing in The Lancet Neurology and European Journal of Heart Failure.

Best Publications

  • Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

    Elliott Antman;Jean-Pierre Bassand;Werner Klein;Magnus Ohman

  • European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

    J Perk;G De Backer;H Gohlke;I Graham

  • Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction

    J. S. Alpert;E. Antman;F. Apple;P. W. Armstrong

  • ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)

    Lars Ryden;Peter J. Grant;Stefan D. Anker;Christian Berne

  • Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

    Lars Rydén;Eberhard Standl;Małgorzata Bartnik;Greet Van den Berghe

  • Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year

    Klas Malmberg;Lars Rydén;Suad Efendic;Johan Herlitz

  • Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais

  • Basal insulin and cardiovascular and other outcomes in dysglycemia

    Origin Trial Investigators;Hertzel C Gerstein;Jackie Bosch;Gilles R Dagenais

  • Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure

    Milton Packer;Philip A. Poole-Wilson;Paul W. Armstrong;John G. F. Cleland

  • Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

    Anna Norhammar;Åke Tenerz;Göran Nilsson;Anders Hamsten

  • Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

    K Malmberg;Lars Rydén;H Wedel;K Birkeland

  • Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

    Å Hjalmarson;Johan Herlitz;I Málek;L Rydén

  • 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

    Massimo F. Piepoli;Arno W. Hoes

  • Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

    Karl Swedberg;Peter Held;John Kjekshus;Knut Rasmussen

  • 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    L. Samuel Wann;Anne B. Curtis;Kenneth A. Ellenbogen;N.A. Mark Estes

  • Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction Long-Term Results From the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study

    Klas Malmberg;Anna Norhammar;Hans Wedel;Lars Rydén

  • 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Valentin Fuster;Lars E. Rydén;Davis S. Cannom;Harry J. Crijns

  • ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)

    Valentin Fuster;Lars E. Rydén;David S. Cannom;Harry J. Crijns

  • European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

    Joep Perk;Guy De Backer;Helmut Gohlke;Ian Graham

  • ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

    Valentin Fuster;Lars E. Rydén;David S. Cannom;Harry J. Crijns

Frequent Co-Authors

David R. Wood
David R. Wood Monash University
Dirk De Bacquer
Dirk De Bacquer Ghent University
Jaakko Tuomilehto
Jaakko Tuomilehto University of Helsinki
Hertzel C. Gerstein
Hertzel C. Gerstein McMaster University
Jeffrey L. Probstfield
Jeffrey L. Probstfield University of Washington
Renata Cifkova
Renata Cifkova Charles University
Guy De Backer
Guy De Backer Ghent University
Rafael Diaz
Rafael Diaz University of Alberta
Salim Yusuf
Salim Yusuf McMaster University
Kerstin Brismar
Kerstin Brismar Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens doors to various related fields and flexible online degree options. For those interested in leadership roles within healthcare, earning an accelerated healthcare administration degree can be a fast track to management positions and policy roles in hospitals or clinics.

Registered nurses aiming to become nurse practitioners can benefit from adn to np programs online. These bridge programs allow working nurses to advance their education and clinical skills while maintaining their careers.

For those passionate about nutrition and preventative care, an online dietitian degree provides a convenient path to becoming a certified dietitian or nutritionist. This specialty is vital for supporting patient health and wellness in a variety of settings.

If your ambition is to lead in healthcare administration, consider one of the top cahme-accredited mha programs online. These programs are recognized for their rigorous standards and prepare graduates for executive roles across healthcare organizations.

Exploring these online degrees can expand your career options and allow you to make a meaningful difference in the healthcare field.

Best Scientists Citing Lars Rydén

Trending Scientists

Recently Published Articles